Guided Therapeutics (GTHP) Cash from Investing Activities (2020 - 2022)

Guided Therapeutics' Cash from Investing Activities history spans 8 years, with the latest figure at -$3000.0 for Q4 2022.

  • On a quarterly basis, Cash from Investing Activities rose 25.0% to -$3000.0 in Q4 2022 year-over-year; TTM through Dec 2025 was -$3000.0, a 82.35% increase, with the full-year FY2025 number at -$2000.0, changed N/A from a year prior.
  • Cash from Investing Activities hit -$3000.0 in Q4 2022 for Guided Therapeutics, up from -$14000.0 in the prior quarter.
  • Over the last five years, Cash from Investing Activities for GTHP hit a ceiling of -$1000.0 in Q3 2020 and a floor of -$14000.0 in Q1 2022.
  • Historically, Cash from Investing Activities has averaged -$4571.4 across 3 years, with a median of -$4000.0 in 2021.
  • The widest YoY moves for Cash from Investing Activities: up 25.0% in 2022, down 1300.0% in 2022.
  • Tracing GTHP's Cash from Investing Activities over 3 years: stood at -$1000.0 in 2020, then plummeted by 300.0% to -$4000.0 in 2021, then increased by 25.0% to -$3000.0 in 2022.
  • Business Quant data shows Cash from Investing Activities for GTHP at -$3000.0 in Q4 2022, -$14000.0 in Q1 2022, and -$4000.0 in Q4 2021.